TY - JOUR
AU - C. A. Poland
AU - J. M. Shadur
AU - M. Cinader
AU - J. W. Felton
A1 - 
AB - OBJECTIVE: Pregnant people receiving treatment for opioid use disorders (OUD) are at significant risk of return to use during the postpartum period. Recently, practice groups and other national organizations have called for the co-location of addiction medicine and obstetric care to reduce the burden on pregnant and postpartum people with OUD associated with engaging in treatment. This paper examines the effectiveness of co-locating services in retaining pregnant people with OUD in care following childbirth. METHODS: A records review of pregnant people receiving medication for OUD between 2012 and 2017 in stand-alone addiction medicine clinic (n = 23) and from 2017 to 2021 following the creation of an integrated addiction medicine-obstetric care clinic (n = 67) was conducted to compared rates of attendance in both obstetric and addiction medicine services. RESULTS: Findings from this study suggest that individuals receiving services in a co-located clinic had significantly fewer missed appointments during the postpartum period relative to individuals who sought care at separate addiction medicine and obstetric care clinics. CONCLUSIONS: Results from this study support the potential for co-locating clinics to reduce barriers to accessing obstetric and addiction medicine services, as well as support continued attendance in care across a vulnerable period.
AD - Department of Obstetrics, Gynecology and Reproductive Health Michigan State University East Lansing Michigan USA.; School of Integrative Studies and Human Development and Family Science George Mason University Fairfax Virginia USA.; Department of Psychiatry Michigan State University East Lansing Michigan USA.; Center for Health Policy & Health Services Research Henry Ford Health Detroit Michigan USA.
AN - 38854870
BT - Psychiatr Res Clin Pract
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 2
DA - Summer
DO - 10.1176/appi.prcp.20230033
DP - NLM
ET - 20231209
IS - 2
JF - Psychiatr Res Clin Pract
LA - eng
N2 - OBJECTIVE: Pregnant people receiving treatment for opioid use disorders (OUD) are at significant risk of return to use during the postpartum period. Recently, practice groups and other national organizations have called for the co-location of addiction medicine and obstetric care to reduce the burden on pregnant and postpartum people with OUD associated with engaging in treatment. This paper examines the effectiveness of co-locating services in retaining pregnant people with OUD in care following childbirth. METHODS: A records review of pregnant people receiving medication for OUD between 2012 and 2017 in stand-alone addiction medicine clinic (n = 23) and from 2017 to 2021 following the creation of an integrated addiction medicine-obstetric care clinic (n = 67) was conducted to compared rates of attendance in both obstetric and addiction medicine services. RESULTS: Findings from this study suggest that individuals receiving services in a co-located clinic had significantly fewer missed appointments during the postpartum period relative to individuals who sought care at separate addiction medicine and obstetric care clinics. CONCLUSIONS: Results from this study support the potential for co-locating clinics to reduce barriers to accessing obstetric and addiction medicine services, as well as support continued attendance in care across a vulnerable period.
PY - 2024
SN - 2575-5609
SP - 36
EP - 41+
ST - Co-Locating Obstetrics and Addiction Medicine Clinics to Improve Attendance in Services for Pregnant People with Opioid Use Disorder
T1 - Co-Locating Obstetrics and Addiction Medicine Clinics to Improve Attendance in Services for Pregnant People with Opioid Use Disorder
T2 - Psychiatr Res Clin Pract
TI - Co-Locating Obstetrics and Addiction Medicine Clinics to Improve Attendance in Services for Pregnant People with Opioid Use Disorder
U1 - Healthcare Disparities; Opioids & Substance Use
U3 - 10.1176/appi.prcp.20230033
VL - 6
VO - 2575-5609
Y1 - 2024
ER -